| Literature DB >> 27915400 |
Maurizio Forte1, Cristina Nocella2, Elena De Falco2, Silvia Palmerio2, Leonardo Schirone2, Valentina Valenti3, Giacomo Frati1,2, Roberto Carnevale1, Sebastiano Sciarretta4,5.
Abstract
NADPH oxidases (NOXs) represent one of the major sources of reactive oxygen species in the vascular district. Reactive oxygen species are responsible for vascular damage that leads to several cardiovascular pathological conditions. Among NOX isoforms, NOX2 is widely expressed in many cells types, such as cardiomyocytes, endothelial cells, and vascular smooth muscle cells, confirming its pivotal role in vascular pathophysiology. Studies in mice models with systemic deletion of NOX2, as well as in transgenic mice overexpressing NOX2, have demonstrated the undeniable involvement of NOX2 in the development of hypertension, atherosclerosis, diabetes mellitus, cardiac hypertrophy, platelet aggregation, and aging. Of note, the inhibition of NOX2 has been found to be protective for cardiovascular homeostasis. Here, we review the evidence demonstrating that the modulation of NOX2 activity is able to improve vascular physiology, suggesting that NOX2 may be a potential target for therapeutic applications.Entities:
Keywords: Cardiac hypertrophy; Hypertension; NADPH oxidase; NOX2; Reactive oxygen species
Mesh:
Substances:
Year: 2016 PMID: 27915400 DOI: 10.1007/s40292-016-0175-y
Source DB: PubMed Journal: High Blood Press Cardiovasc Prev ISSN: 1120-9879